These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 7985890)
1. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. La Rosa GL; Lupo L; Giuffrida D; Gullo D; Vigneri R; Belfiore A Ann Intern Med; 1995 Jan; 122(1):1-8. PubMed ID: 7985890 [TBL] [Abstract][Full Text] [Related]
2. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571 [TBL] [Abstract][Full Text] [Related]
3. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. Bennedbaek FN; Nielsen LK; Hegedüs L J Clin Endocrinol Metab; 1998 Mar; 83(3):830-5. PubMed ID: 9506736 [TBL] [Abstract][Full Text] [Related]
4. Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Koc M; Ersoz HO; Akpinar I; Gogas-Yavuz D; Deyneli O; Akalin S Clin Endocrinol (Oxf); 2002 Nov; 57(5):621-8. PubMed ID: 12390336 [TBL] [Abstract][Full Text] [Related]
5. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. Wémeau JL; Caron P; Schvartz C; Schlienger JL; Orgiazzi J; Cousty C; Vlaeminck-Guillem V J Clin Endocrinol Metab; 2002 Nov; 87(11):4928-34. PubMed ID: 12414852 [TBL] [Abstract][Full Text] [Related]
6. Changes in both size and cytological features of thyroid nodule after levothyroxine treatment. Vermiglio F; Lo Presti VP; Violi MA; Moleti M; Castagna MG; Finocchiaro MD; Mattina F; Mandolfino M; Zimbaro G; Trimarchi F Clin Endocrinol (Oxf); 2003 Sep; 59(3):347-53. PubMed ID: 12919158 [TBL] [Abstract][Full Text] [Related]
7. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy. Puzziello A; Carrano M; Angrisani E; Marotta V; Faggiano A; Zeppa P; Vitale M J Endocrinol Invest; 2014 Dec; 37(12):1181-6. PubMed ID: 25008459 [TBL] [Abstract][Full Text] [Related]
8. [Levothyroxine treatment of the solitary thyroid nodule]. Almodóvar Ruiz F; Maldonado Castro G; de Luis D; Lahera M; Varela da Costa C An Med Interna; 2000 Feb; 17(2):99-101. PubMed ID: 10829467 [TBL] [Abstract][Full Text] [Related]
9. Suppressive therapy with levothyroxine for solitary thyroid nodules. Reverter JL; Lucas A; Salinas I; Audí L; Foz M; Sanmartí A Clin Endocrinol (Oxf); 1992 Jan; 36(1):25-8. PubMed ID: 1559296 [TBL] [Abstract][Full Text] [Related]
13. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules. Celani MF; Mariani M; Mariani G Acta Endocrinol (Copenh); 1990 Dec; 123(6):603-8. PubMed ID: 2284885 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of thyroxine and potassium iodide treatment of benign nodular thyroid lesions]. Grineva EN; Malakhova TV; Tsoĭ UA; Smirnov BI Ter Arkh; 2003; 75(8):72-5. PubMed ID: 14520857 [TBL] [Abstract][Full Text] [Related]
15. Levothyroxine treatment in pediatric benign thyroid nodules. Corrias A; Mussa A; Wasniewska M; Segni M; Cassio A; Salerno M; Gastaldi R; Vigone MC; Bal M; Matarazzo P; Weber G; De Luca F Horm Res Paediatr; 2011; 75(4):246-51. PubMed ID: 21135537 [TBL] [Abstract][Full Text] [Related]
16. Is percutaneous ethanol injection a useful alternative for the treatment of the cold benign thyroid nodule? Five years' experience. Caraccio N; Goletti O; Lippolis PV; Casolaro A; Cavina E; Miccoli P; Monzani F Thyroid; 1997 Oct; 7(5):699-704. PubMed ID: 9349572 [TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Papini E; Bacci V; Panunzi C; Pacella CM; Fabbrini R; Bizzarri G; Petrucci L; Giammarco V; La Medica P; Masala M Clin Endocrinol (Oxf); 1993 May; 38(5):507-13. PubMed ID: 8330445 [TBL] [Abstract][Full Text] [Related]
18. Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. Cheung PS; Lee JM; Boey JH World J Surg; 1989; 13(6):818-21; discussion 822. PubMed ID: 2696232 [TBL] [Abstract][Full Text] [Related]
19. [Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results]. Wémeau JL; Cousty C; Vlaeminck V Ann Endocrinol (Paris); 2000 May; 61(2):119-24. PubMed ID: 10891662 [TBL] [Abstract][Full Text] [Related]
20. Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women. Costante G; Crocetti U; Schifino E; Ludovico O; Capula C; Nicotera M; Arturi F; Filetti S J Endocrinol Invest; 2004 Jan; 27(1):31-6. PubMed ID: 15053240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]